RA
Raphael Pharmaceutical Inc.
RAPH · OTC
$1.40 +0.00% (+$0.00)
Market Cap $28.2M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A EV/FFO N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 14,000.00%
Asset turnover 0.00x
ROIC 50.33%
Debt
0 /100
High Int. coverage -17.49x
Current ratio 0.00x
Net debt/EBITDA N/A
Stability
1 /100
Unstable EPS volatility 94.94%
Profitable years 0
Beta 1.90x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RAPH
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Shlomo Pilo
Employees
0
Headquarters
Jaffa